In Silico Studies of Potent Tyrosine Kinase Inhibitors: Molecular Docking and Pharmacophore Modeling Approaches. [PDF]
Mavridis E +2 more
europepmc +1 more source
Pharmacophore mapping identifies the key molecular features and their 3D spatial relationships required for a molecule to have biological activity. The process involves defining these features (like hydrogen bond donors/acceptors, hydrophobic groups, and charges), finding the correct conformations for active molecules, and using these models to align ...
openaire +1 more source
<i>In silico</i> design and binding mechanism of UBR1 E3 ligase recruiters. [PDF]
Maria-Solano MA, Lazim R, Choi S.
europepmc +1 more source
Structure-based pharmacophore modeling, high-throughput screening, and molecular dynamics identify a novel DrugBank-derived HIV-1 protease inhibitor. [PDF]
Khazaal Nazal AS +3 more
europepmc +1 more source
Integrated Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulations Accelerate the Discovery of Novel PDE1 Inhibitors with Potential for the Treatment of Idiopathic Pulmonary Fibrosis. [PDF]
Cai XL +6 more
europepmc +1 more source
Structure-Guided Discovery of Selective Polo-Like Kinase 3 Inhibitors. [PDF]
Yap JL +26 more
europepmc +1 more source
DEL2PH4: Predictive 3D Pharmacophores from DNA-Encoded Library Screening Data. [PDF]
Feher M +4 more
europepmc +1 more source
Integrative Computational Chemistry Approaches in Modern Drug Discovery: Advances in Docking, Pharmacophore Modeling, Molecular Dynamics, and Virtual Screening. [PDF]
Altharawi A, Alqahtani SM.
europepmc +1 more source
Ligand-Based Pharmacophore Modeling and Structure-Based Virtual Screening for Identifying Potential Therapeutic Agents Targeting the SARS-CoV-2 Spike Protein-ACE2 Receptor Interaction. [PDF]
Delgado-Maldonado T +5 more
europepmc +1 more source
Targeting the Glucokinase-Glucokinase Regulatory Protein Axis: Pharmacophore-Based Identification of Novel Antidiabetic Small Molecules. [PDF]
Paliwal A +4 more
europepmc +1 more source

